Close Menu
Home » Quanterix to Acquire UmanDiagnostics for $22.5M

Quanterix to Acquire UmanDiagnostics for $22.5M

Jun 26, 2019
|
staff reporter

NEW YORK – Quanterix announced after the close of the market on Wednesday that it has inked an agreement to acquire privately held UmanDiagnostics for $22.5 million.

Quanterix will pay Uman $16 million in cash and $6.5 million in Quanterix common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lawsuit on Not Knowing Father's Test Result

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

Lots and Lots of Triglycerides

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

Image Errors Investigated

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

PNAS Studies on Supercentenarians, Blood Cell Differentiation in AML, Beetle Evolution

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.

What's Popular?

In Business News

  1. Qiagen Says It Is Fielding Acquisition Offers

  2. Roche to Buy up to $2B of Notes

  3. Personalis, Merck KGaA to Study Cancer Biomarkers Using Immunogenomics Platform

  4. Cancer Diagnostics Firm Lucence Raises $20M

  5. Exact Sciences Marker Panel Detects Early Liver Cancer With Triple Sensitivity of Current Biomarker

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.